Biotech | November 26, 2025
Novartis scores FDA nod for game-changing SMA treatment
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
The new site enables end-to-end production of viral vector gene therapies
The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
Subscribe To Our Newsletter & Stay Updated
